| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 117 |
| 1 | FUROSEMIDE | 116 |
| 2 | ASPIRIN 325 MG | 112 |
| 3 | ASPIRIN 81 MG | 112 |
| 4 | PANTOPRAZOLE | 88 |
| 5 | FENFLURAMINE | 80 |
| 6 | ACETAMINOPHEN | 70 |
| 7 | METOPROLOL TARTRATE | 64 |
| 8 | METOPROLOL | 62 |
| 9 | METHOTREXATE SODIUM | 60 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLUENZA A VIRUS A/VICTORIA/2570/2019 IVR-215 (H1N1) HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/DARWIN/9/2021 IVR-228 (H3N2) HEMAGGLUTININ ANTIGEN (UV, FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/MICHIGAN/01/2021 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/PHUKET/3073/2013 HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED | 1 | 0.5000 |
| 1 | PAROMOMYCIN SULFATE | 4 | 0.0377 |
| 2 | MECLOFENAMATE SODIUM | 2 | 0.0364 |
| 3 | CHLORINE | 2 | 0.0317 |
| 4 | FENFLURAMINE | 80 | 0.0152 |
| 5 | NILUTAMIDE | 1 | 0.0135 |
| 6 | GUAIFENESIN AND CODEINE PHOSPHATE | 1 | 0.0075 |
| 7 | AMOXAPINE | 3 | 0.0063 |
| 8 | CHLOROQUINE PHOSPHATE | 4 | 0.0061 |
| 9 | BUTALBITAL, ASPIRIN, AND CAFFEINE | 1 | 0.0058 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 207 |
| 1 | Corticosteroid [EPC] | 146 |
| 2 | Loop Diuretic [EPC] | 140 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 123 |
| 4 | beta-Adrenergic Blocker [EPC] | 115 |
| 5 | Benzodiazepine [EPC] | 98 |
| 6 | Angiotensin 2 Receptor Blocker [EPC] | 97 |
| 7 | Proton Pump Inhibitor [EPC] | 80 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 76 |
| 9 | Vitamin C [EPC] | 60 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tricyclic Antidepressant [EPC] | 3 | 0.0063 |
| 1 | Melanocortin 4 Receptor Agonist [EPC] | 1 | 0.0035 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 26 | 0.0020 |
| 3 | Methylating Agent [EPC] | 2 | 0.0019 |
| 4 | Carnitine Analog [EPC] | 5 | 0.0014 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 28 | 0.0013 |
| 6 | Polyene Antifungal [EPC] | 37 | 0.0009 |
| 7 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 8 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 9 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 7 | 0.0007 |